TickerFactsScreenerDevelopers

Ovid Therapeutics Inc. (OVID) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $32.1K2016: $30.4K2017: $38.9K2018: $33.9K2019: $57.2K2020: $127.2K2021: $184.0K2022: $1.22M2023: $40.0K2024: $71.0K2025: $0$0
2015Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$0-100.0%
2024$71.0K+77.5%
2023$40.0K-96.7%
2022$1.22M+565.4%
2021$184.0K+44.6%
2020$127.2K+122.6%
2019$57.2K+68.7%
2018$33.9K-12.9%
2017$38.9K+28.1%
2016$30.4K-5.4%
2015$32.1K—